United States President Donald Trump has announced a new deal with British pharmaceutical giant AstraZeneca to supply discounted medicines to the country's Medicaid programme in exchange for tariff relief.
According to statement released by the White House, the new arrangement with AstraZeneca requires the company to adopt a 'most-favoured-nation' pricing model to ensure that Medicaid pays no more than the lowest prices available across other advanced economies, including for newly launched drugs.
